scispace - formally typeset
W

Wanpen Chaicumpa

Researcher at Mahidol University

Publications -  6
Citations -  1066

Wanpen Chaicumpa is an academic researcher from Mahidol University. The author has contributed to research in topics: Ebola virus & Glycoprotein. The author has an hindex of 3, co-authored 6 publications receiving 782 citations.

Papers
More filters
Journal ArticleDOI

Coronavirus Disease 2019–COVID-19

TL;DR: Analysis of epidemiological, diagnostic, clinical, and therapeutic aspects, including perspectives of vaccines and preventive measures that have already been globally recommended to counter this pandemic virus, suggest that this novel virus has been transferred from an animal source, such as bats.
Posted ContentDOI

Coronavirus Disease 2019 – COVID-19

TL;DR: Compared to diseases caused by previously known human CoVs, COVID-19 shows less severe pathogenesis but higher transmission competence, as is evident from the continuously increasing number of confirmed cases globally.
Posted ContentDOI

SARS-CoV-2: Jumping the Species Barrier, Lessons from SARS and MERS, Its Zoonotic Spillover, Transmission to Humans, Preventive and Control Measures and Recent Developments to Counter This Pandemic Virus

TL;DR: An overview of COVID-19 and the causative virus SARS-CoV-2 is presented, with particular emphasis on the role of animals and their jumping the cross-species barriers, experiences learned from Sars- and MERS-CoVs, zoonotic links, and spillover events, transmission to humans and rapid spread.
Journal ArticleDOI

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus

TL;DR: In this paper, Phage display technology was used as a tool to isolate human single-chain antibodies that bind to recombinant RBDs from a human scFv (HuscFv) phage display library.
Journal ArticleDOI

Human Monoclonal scFvs that Neutralize Fribrinogenolytic Activity of Kaouthiagin, a Zinc-Metalloproteinase in Cobra (Naja kaouthia) Venom

TL;DR: Human single-chain antibody variable fragments (HuscFvs) that bind to and interfere with kaouthiagin activity for further clinical use have therapeutic potential as an adjunct of antivenins in treatment of bleeding caused by venomous snakebites.